By Alicia J. Jenkins, Peter P. Toth

Diabetes mellitus is a global epidemic, with millions of new cases diagnosed every year. The chronic complications of diabetes are a significant burden for individuals and healthcare systems alike. One key aspect in understanding and managing these complications is the study of lipoproteins. Lipoproteins play a crucial role in the pathogenesis of chronic complications in people with diabetes. “Lipoproteins in Diabetes Mellitus, 2nd Edition” is a comprehensive reference that aims to advance knowledge and contribute to the reduction of the burden associated with altered lipoproteins in people with diabetes.

Lipoproteins in Diabetes Mellitus, 2nd Edition, written by Alicia J. Jenkins and Peter P. Toth, provides an updated and comprehensive review of the field. This book is divided into three main sections to cover various aspects of lipoprotein metabolism, complications of diabetes, and the treatment of lipoproteins in diabetes. Each chapter has been updated from the first edition, and new topics have been added to provide a well-rounded understanding of the subject matter.

The first section covers lipoprotein metabolism, qualitative changes, and measurements. Understanding the metabolism of lipoproteins is crucial in identifying potential targets for therapeutic interventions. The second section delves into the role of lipoproteins in the complications of diabetes. This section explores the impact of lipoproteins on various complications, such as cardiovascular disease, nephropathy, retinopathy, and neuropathy. It also discusses the links between glycemia and lipoproteins, shedding light on the intricate relationship between glucose control and lipoprotein levels. Lastly, the third section focuses on the treatment of lipoproteins in diabetes. It covers topics such as statin intolerance, the use of PCSK9 inhibitors, and fish oils in managing lipoprotein levels in people with diabetes.

One of the notable additions to the second edition is the exploration of the role of lipoproteins in ischemic stroke. Stroke is a significant concern for people with diabetes, and understanding the role of lipoproteins in this context can pave the way for targeted interventions and improved outcomes. Additionally, the book addresses the diagnosis and management of statin intolerance, which is considered more common among individuals with diabetes. The inclusion of these new topics reflects the evolving knowledge and understanding of the field.

What sets this book apart is the international and multidisciplinary approach taken by the authors. The book is written by an international group of experts in the clinical, laboratory, and research aspects of lipoproteins in diabetes. This diverse perspective ensures a comprehensive and well-rounded examination of the subject matter.

“Lipoproteins in Diabetes Mellitus, 2nd Edition” is a must-have resource for primary care and specialist clinicians, clinical and basic science researchers, as well as trainees and students. The book’s comprehensive coverage, updated information, and inclusion of new topics make it an invaluable reference for those involved in the study and management of lipoproteins in diabetes.

Order your copy of “Lipoproteins in Diabetes Mellitus, 2nd Edition” today and embark on a journey to deepen your understanding of the role of lipoproteins in diabetes. Whether you are a healthcare professional seeking to improve patient outcomes or a researcher striving to make advancements in the field, this book will provide you with the knowledge and insights necessary to make a difference.

Product Details

• Publisher: Humana; 2nd ed. 2023 edition (June 17, 2023)
• Language: English
• eBook Digital: 946 pages
• ISBN-10: 3031266803
• ISBN-13: 978-3031266805

Order Now